Santhera Completes Divestment of RaxoneIdebenone Business to Chiesi Group - Benzinga

SPHDF Stock  USD 9.42  0.00  0.00%   
Roughly 61% of Santhera Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Santhera Pharmaceuticals Holding pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Santhera Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Santhera Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Santhera Pharmaceuticals pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Santhera daily returns and investor perception about the current price of Santhera Pharmaceuticals Holding as well as its diversification or hedging effects on your existing portfolios.
  
Santhera Completes Divestment of RaxoneIdebenone Business to Chiesi Group Benzinga

Read at news.google.com
Google News at Macroaxis
  

Santhera Pharmaceuticals Fundamental Analysis

We analyze Santhera Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Santhera Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Santhera Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Return On Equity

Return On Equity Comparative Analysis

Santhera Pharmaceuticals is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Santhera Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Santhera Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Santhera Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Santhera Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Santhera Pharmaceuticals Related Equities

DSGNDesign Therapeutics   6.75   
0%
100.0%
ANABAnaptysBio   6.50   
0%
96.0%
MGTXMeiraGTx Holdings   5.56   
0%
82.0%
IDYAIdeaya Biosciences   4.37   
0%
64.0%
ZVSAZyVersa Therapeutics   4.23   
0%
62.0%
KROSKeros Therapeutics   3.23   
0%
47.0%
BDRXBiodexa Pharmaceticals   2.80   
0%
41.0%
GHRSGH Research   1.24   
0%
18.0%
GNFTGenfit   0.58   
0%
8.0%
IVAInventiva   0.46   
0%
6.0%
ACHLAchilles Therapeutics   0.87   
12.0%
0%
LEXXLexaria Bioscience   4.04   
59.0%
0%

Complementary Tools for Santhera Pink Sheet analysis

When running Santhera Pharmaceuticals' price analysis, check to measure Santhera Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santhera Pharmaceuticals is operating at the current time. Most of Santhera Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Santhera Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santhera Pharmaceuticals' price. Additionally, you may evaluate how the addition of Santhera Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Directory
Find actively traded commodities issued by global exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins